ExAblate is the only FDA approved non-invasive treatment for uterine fibroids using MR guided Focused Ultrasound. ExAblate is CE approved for the treatment of pain palliation of bone tumors.
InSightec is conducting research for oncology applications such as brain tumors, breast cancer and prostate cancer.
Free download:
Transcranial MR guided Focused Ultrasound Surgery: Current Applications and Progress in Non-invasive Neurosurgery.
History of MR guided Focused Ultrasound by Arthur Chan, PhD
A literature review outlining the history of ultrasound as a therapeutic modality from the early 20th century to present day.
Compendium of Focused Ultrasound Clinical Publications
This compendium includes papers describing clinical experience gathered
about Ultrasound Guided systems (in dark blue) and MR Guided systems (in
Black), by multiple vendors. Papers in each section are ordered by date.
ExAblate Bibliography
Outlines published resources with information about MR guided focused ultrasound. Bibliography includes: published papers, books about, or with chapters about MRgFUS and papers accepted for publication.
CME Course: MR Guided Focused Ultrasound Therapy
Currently there is a CME course available on MR guided focused ultrasound therapy for uterine fibroids with Dr. Elizabeth Stewart, Professor of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN.
Presentations on Focused Ultrasound from the MRgFUS Symposium, October, 2010, Washington DC, USA.
Learn about how the ExAblate procedure works.
To find a list of treatment centers where ExAblate is available, click here.
Contact us for more information about MR Guided Focused Ultrasound therapy.


